{Reference Type}: Journal Article
{Title}: Epidemic of parvovirus B19 and disease severity in pregnant people, Denmark, January to March 2024.
{Author}: Nordholm AC;Trier Møller F;Fischer Ravn S;Flink Sørensen L;Moltke-Prehn A;Elskær Mollerup J;Funk T;Sperling L;Jeyaratnam U;Træholt Franck K;Hjort-Pedersen K;Hjørnet Kamper C;Thoft Nielsen R;Jokelainen P;Wessman M;
{Journal}: Euro Surveill
{Volume}: 29
{Issue}: 24
{Year}: 2024 Jun
{Factor}: 21.286
{DOI}: 10.2807/1560-7917.ES.2024.29.24.2400299
{Abstract}: We report an epidemic of parvovirus B19 infections in Denmark during the first quarter of 2024, with a peak incidence 3.5 times higher than during the most recent epidemic in 2017. In total, 20.1% (130/648) of laboratory-confirmed cases were pregnant. Severe adverse outcomes were observed among 12.3% (16/130) of pregnant people and included foetal anaemia, foetal hydrops and miscarriage. Parvovirus B19 infection is not systematically monitored, but a national laboratory-based surveillance system is currently being established in Denmark.